Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Oct 6;15(10):e46575.
doi: 10.7759/cureus.46575. eCollection 2023 Oct.

Prognostic Factors Influencing Survival in Stage II and Stage III Colorectal Cancer Patients

Mohammad S Alkader  1 , Murad Z Al-Majthoub  2 , Walid A Al-Qerem  3 , Doa'a M Alkhader  4 , Aseel M Alhusban  2 , Muna A Abdulkareem  2 , Bashar Abweny  2 , Alaa T Hamawi  2 , Hala F Muslem  2 , Rasha A Omeish  2 , AlAnoud M Al-Adwan  5 , Hamed A Al Halaiqah  6
Affiliations

Prognostic Factors Influencing Survival in Stage II and Stage III Colorectal Cancer Patients

Mohammad S Alkader et al. Cureus. .

Abstract

Background Colorectal cancer (CRC) is a global health concern with rising incidence. This study analyzed demographic and clinicopathological factors influencing overall survival (OS) and disease-free survival (DFS) in Jordanian CRC patients. Methodology This retrospective, single-center study collected data from CRC patients at the Royal Medical Services, Jordan, from January 2018 to June 2020. Patient variables included disease stage, stage risk, tumor location, history of chemotherapy, and metastasis status. OS and DFS were defined as the time from surgery to death, last follow-up, or metastasis confirmation. Kaplan-Meier curves and Cox models were used for survival analysis. Results Of 127 CRC patients, 33.3% died during the follow-up period. Most patients were males (55.1%), diagnosed with stage III (55.9%), and classified as high risk (59.2%). Metastasis occurred in 24.4%, and 65.4% received chemotherapy. OS at one, two, and end of the follow-up years was 85.2%, 75.6%, and 66.9%, respectively. Metastasis-free rates were 85%, 78.5%, and 71%, respectively. Multivariate analysis showed that stage III (hazard ratio (HR) = 2.968) and high-risk stage (HR = 2.966) were associated with shorter OS and increased metastasis risk. Right-sided tumors (HR = 2.183) had shorter OS, while chemotherapy recipients (HR = 0.430) had longer OS. Stage III and high-risk stages were strong predictors of mortality, while only stage III and high-risk stages were robust predictors of metastasis. Demographic variables (sex and age) showed no significant associations with survival outcomes. Conclusions Our findings highlight the prognostic significance of disease stage, stage risk, tumor location, and chemotherapy in CRC survival among Jordanian patients. Understanding these factors can guide tailored treatment and improve outcomes.

Keywords: chemotherapy; colorectal cancer; disease-free survival (dfs); jordan; overall survival (os); prognosis.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Survival patterns over time.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Colorectal cancer statistics, 2023. Siegel RL, Wagle NS, Cercek A, Smith RA, Jemal A. CA Cancer J Clin. 2023;73:233–254. - PubMed
    1. Multiomics of colorectal cancer organoids reveals putative mediators of cancer progression resulting from SMAD4 inactivation. Dijkstra JJ, Neikes HK, Rezaeifard S, Ma X, Voest EE, Tauriello DV, Vermeulen M. J Proteome Res. 2023;22:138–151. - PMC - PubMed
    1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. CA Cancer J Clin. 2021;71:209–249. - PubMed
    1. Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors. Rawla P, Sunkara T, Barsouk A. Prz Gastroenterol. 2019;14:89–103. - PMC - PubMed
    1. Knowledge and perceptions about colorectal cancer in Jordan. Taha H, Jaghbeer MA, Shteiwi M, AlKhaldi S, Berggren V. Asian Pac J Cancer Prev. 2015;16:8479–8486. - PubMed

LinkOut - more resources